{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:50Z","timestamp":1791262430246,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110511","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:43:18Z","timestamp":1789515798000},"page":"110511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-guided design of N-alkylated benzazepine derivatives as potential CETP inhibitors"],"prefix":"10.1016","volume":"182","author":[{"given":"Sudipta","family":"Nandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sumit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrapal Singh","family":"Aidhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Senapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110511_bb0005","unstructured":"World Health Organization, Cardiovascular diseases fact sheet, 2025 Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) (accessed 2021)."},{"key":"10.1016\/j.bioorg.2026.110511_bb0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.bioorg.2026.110511_bb0015","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110511_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100701","article-title":"Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond","volume":"19","author":"Safarova","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110511_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-18445-6","article-title":"The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990\u20132019","volume":"24","author":"Tong","year":"2024","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110511_bb0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110511_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/364073a0","article-title":"Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein","volume":"364","author":"Marotti","year":"1993","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110511_bb0040","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioorg.2026.110511_bb0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cca.2020.09.012","article-title":"Cholesteryl ester transfer protein inhibitors in precision medicine","volume":"510","author":"Su","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"9539","key":"10.1016\/j.bioorg.2026.110511_bb0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(06)69292-1","article-title":"Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study","volume":"368","author":"Deedwania","year":"2006","journal-title":"Lancet"},{"issue":"6792","key":"10.1016\/j.bioorg.2026.110511_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35018119","article-title":"A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits","volume":"406","author":"Okamoto","year":"2000","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110511_bb0060","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of Torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110511_bb0065","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110511_bb0070","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110511_bb0075","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of Dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110511_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.phrs.2017.12.028","article-title":"Present therapeutic role of cholesteryl ester transfer protein inhibitors","volume":"128","author":"Ferri","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110511_bb0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000505365","article-title":"Cholesteryl ester transfer protein inhibitors and cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Taheri","year":"2020","journal-title":"Cardiology"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110511_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/14779072.2020.1745633","article-title":"The mystery of Evacetrapib \u2013 why are CETP inhibitors failing?","volume":"18","author":"Nicholls","year":"2020","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.bioorg.2026.110511_bb0095","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1194\/jlr.M018069","article-title":"Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure","volume":"52","author":"Cao","year":"2011","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110511_bb0100","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.21037\/jtd.2017.07.75","article-title":"Evacetrapib and cardiovascular outcomes: reasons for lack of efficacy","volume":"9","author":"Filippatos","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.bioorg.2026.110511_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0079-6468(08)70290-X","article-title":"Medicinal chemistry of 1-benzazepines","volume":"27","author":"Hino","year":"1990","journal-title":"Prog. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110511_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/cr040415t","article-title":"Synthesis and pharmacology of galantamine","volume":"106","author":"Marco-Contelles","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110511_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200617","article-title":"A synthetic overview of benzoxazines and benzoxazepines as anticancer agents","volume":"18","author":"Chatterjee","year":"2023","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110511_bb0120","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/jm020528+","article-title":"Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein","volume":"46","author":"Reinhard","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpba.2017.05.029","article-title":"Development of an in vivo-relevant drug product performance method for an amorphous solid dispersion","volume":"142","author":"Pack","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2026.110511_bb0130","series-title":"Evacetrapib: Uses, Interactions, Mechanism of Action | DrugBank","year":"2026"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110511_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nsmb1197","article-title":"Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules","volume":"14","author":"Qiu","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"44","key":"10.1016\/j.bioorg.2026.110511_bb0140","doi-asserted-by":"crossref","first-page":"37321","DOI":"10.1074\/jbc.M112.380063","article-title":"Crystal structures of cholesteryl ester transfer protein in complex with inhibitors","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11883-023-01087-1","article-title":"Structure-based mechanism and inhibition of cholesteryl ester transfer protein","volume":"25","author":"Xue","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110511_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500562","article-title":"Decoding structural fingerprints to design and elucidate the mechanism of action of prospective cholesteryl ester transfer protein drugs","volume":"20","author":"Nandi","year":"2025","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110511_bb0155","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110511_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002708","article-title":"CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures","volume":"8","author":"Chovancova","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"37","key":"10.1016\/j.bioorg.2026.110511_bb0165","doi-asserted-by":"crossref","first-page":"19462","DOI":"10.1074\/jbc.M116.744623","article-title":"Structural plasticity of cholesteryl ester transfer protein assists the lipid transfer activity","volume":"291","author":"Chirasani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0170","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1021\/acs.jpcb.6b01928","article-title":"Mechanism of inhibition of cholesteryl Ester transfer protein by small molecule inhibitors","volume":"120","author":"Chirasani","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.110511_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jhet.4932","article-title":"Synthesis of 5- aryltetrahydrobenzazepines","volume":"62","author":"Thoti","year":"2025","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0180","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1021\/jo00987a028","article-title":"Phosphorus pentoxide- methanesulfonic acid. A convenient alternative to polyphosphoric acid","volume":"38","author":"Eaton","year":"1973","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0185","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1016\/j.bmcl.2003.07.017","article-title":"Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials","volume":"13","author":"Johnson","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110511_bb0190","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1002\/ejoc.201600549","article-title":"Cs2CO3-promoted direct N-alkylation: highly chemoselective synthesis of N-alkylated benzylamines and anilines","volume":"22","author":"Castillo","year":"2016","journal-title":"Eur. J. Org. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110511_bb0195","article-title":"Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110511_bb0200","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1074248414529621","article-title":"Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study","volume":"19","author":"Gotto","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110511_bb0205","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110511_bb0210","series-title":"ChemDraw","author":"Revvity Signals Software, Inc.","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110511_bb0215","series-title":"Gaussian16 Revision C.01","author":"Frisch","year":"2016"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110511_bb0220","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110511_bb0230","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jcc.1078","article-title":"An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase","volume":"22","author":"Schuler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110511_bb0235","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110511_bb0240","series-title":"OriginLab Corporation","author":"OriginPro","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110511_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeliness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110511_bb0250","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110511_bb0255","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110511_bb0260","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:29Z","timestamp":1791260609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S0045206826010473"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110511","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided design of N-alkylated benzazepine derivatives as potential CETP inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110511"}}